Meta Health (SGX:5DX) received a listing and quotation notice from the SGX for listing 23,331,000 consideration shares as part of its acquisition of Jas Medical Screening, a filing with the Singapore Exchange on Wednesday.
The LQN also includes the listing and quotation of 15,554,000 earn-out shares to be issued to Lek. Under the revised terms, earn-out shares will be issued if Jas Medical achieves net profits of at least SG$175,000 in 2025 and 2026, with adjustments linked to changes in Meta's share base.
Meanwhile up to 2,755,400 shares have been allotted as introducer shares.
In an earlier filing, the company had entered into a sale and purchase agreement with Lian Ah Lek to acquire a 55% stake in Jas Medical Screening Centre for SG$533,310.
Of the total consideration, SG$300,000 was payable in cash while 23,331,100 Meta shares were to be allotted and issued to the vendor at an issue price of SG$0.01 apiece, against a 55% stake in the medical screening company.
Shares of the medical services company crashed over 14% in recent trading.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.